Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Breast Cancer
Sep 27, 2024, 13:26 |
Blog
Yara Abdou: Navigating Treatment pathways in Metastatic HR+ Breast cancer
Yara Abdou shared a post on X: "With the expanding arsenal of endocrine & targeted…
Sep 26, 2024, 14:07 |
Blog
Paolo Tarantino: Why didn’t Datopotamab Deruxtecan improve OS in HR+/HER2- metastatic breast cancer
Paolo Tarantino shared a post on X: ''Why didn’t Datopotamab Deruxtecan improve overall survival in hormone…
Sep 25, 2024, 16:31 |
Blog
Elisa Agostinetto: Datopotamab-Deruxtecan in HR+/HER2-low or negative metastatic breast cancer
Elisa Agostinetto shared a post on X: ''A press release from industry announces that TROPION-Breast01…
Sep 24, 2024, 09:22 |
Blog
Matthew Kurian: Joyce O'Shaughnessy about the current landscape and recent updates in breast cancer!
Matthew Kurian, Staff Oncologist at St. Elizabeth Healthcare, shared a post on LinkedIn: "Calling all…
Sep 24, 2024, 09:07 |
Blog
Guilherme Nader Marta: Global study on young BRCA carriers with breast cancer
Guilherme Nader Marta, Oncology Fellow at Jules Bordet Institute, shared a post by Elisa Agostinetto,…
Sep 24, 2024, 09:03 |
Blog
Vas Narasimhan: US FDA has approved our CDK4/6 inhibitor to reduce risk of recurrence in people with HR+/HER2 early breast cancer
Vas Narasimhan posted on LinkedIn: "I’m proud to share the news that the US FDA…
Sep 23, 2024, 14:23 |
Blog
Tatiana Prowell: Ribociclib is now FDA-approved for stage 2 and 3 hormone receptor positive, HER2 negative breast cancer
Erika Hamilton shared on X by Tatiana Prowell, additing: ''Well isn't this a gift for…
Sep 23, 2024, 09:00 |
Insight
Theodoros Kontoulis: Heterogeneity of residual disease (RD) after NACT in breast cancer
Theodoros Kontoulis shared on LinkedIn: “Most viewed in the last 7 days from JAMA Oncology:…
Sep 22, 2024, 17:46 |
Blog
Francisco J. Esteva: KEYNOTE-522 Trial Shows Pembrolizumab Boosts Survival in Triple-Negative Breast Cancer
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital, posted the…
Sep 21, 2024, 13:07 |
Blog
Olubukola Ayodele about HER2 low breast cancer
Olubukola Ayodele shared a post on LinkedIn: ''Let's talk about HER2 low breast cancer. The…
54
55
56
57
58
All:
2726
Posts:
551 - 560
Dikembe Mutombo: In Memory of Basketball Icon Who Died at 58 Battling Brain Cancer
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 7
César Milstein - The Father of Modern Immunology
ESTRO: Everything You Need to Know About European Society for Radiotherapy and Oncology
Jane Fonda Breast Cancer and Non-Hodgkin Lymphoma: How She Went Against, How She Survived, and More
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube